Startseite Human growth hormone (GH) immunoassay: standardization and clinical implications
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Human growth hormone (GH) immunoassay: standardization and clinical implications

  • Cinzia Carrozza EMAIL logo , Rosa Lapolla , Giulia Canu , Francesca Annunziata , Eleonora Torti , Silvia Baroni und Cecilia Zuppi
Veröffentlicht/Copyright: 2. März 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: The poor comparability of growth hormone (GH) results obtained using commercially available methods, is partly due to standard preparations used in calibration. The system relies on the use of the International Reference Preparation (IRP) international standard (IS) 80/505, of human pituitary origin, containing all GH isoforms. Recently, a 22K recombinant GH isoform IRP IS 98/574 was commercialized. Our aim was to evaluate the influence of both calibrators on GH results.

Methods: GH concentration in 97 serum samples from children undergoing a growth hormone releasing hormone+arginine stimulation test was measured using Siemens IMMULITE electro-chemiluminescence method, calibrated with both IS 80/505 and IS 98/574 (GRH Growth hormone-Recombinant 98/574-kit).

Results: Comparison of our results obtained with the two sets of calibrators showed good correlation, although we found higher percentage variation (var%) than that stated by Siemens. The mean var% value was confirmed when all results were sub-divided into subgroups based on both high and low GH concentrations.

Conclusions: Since the GH assay is influenced by a variety of binding proteins, isoforms and conversion factors, standardization of the assay is strongly required. In Italy, the Agenzia Italiana del Farmaco 39 note provides GH laboratory values which are useful for therapy. On the basis of our results, we therefore propose to adjourn these GH values in order to ensure better management of patients with GH-related disorders.


Corresponding author: Cinzia Carrozza, Catholic University School of Medicine, Largo A Gemelli 8, Rome 00168, Italy Phone: +39-0630154222, Fax: +39-0630156783

Received: 2010-9-15
Accepted: 2010-12-7
Published Online: 2011-03-02
Published in Print: 2011-05-01

©2011 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorials
  2. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?
  3. Circulating macrocomplexes: old wine in new bottles?
  4. Review
  5. Laboratory assessment of new anticoagulants
  6. Minireviews
  7. Biomarkers in Alzheimer’s disease
  8. Analytical variability in sport hematology: its importance in an antidoping setting
  9. The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation
  10. Opinion Paper
  11. Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality
  12. Genetics and Molecular Diagnostics
  13. Genetic variability of the fructosamine 3-kinase gene in diabetic patients
  14. Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
  15. Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition
  16. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
  17. General Clinical Chemistry and Laboratory Medicine
  18. Quality Indicators in Laboratory Medicine: from theory to practice
  19. Implementation of computerized add-on testing for hospitalized patients in a large academic medical center
  20. Human growth hormone (GH) immunoassay: standardization and clinical implications
  21. Coagulation assays based on the Luminescent Oxygen Channeling Immunoassay technology1)
  22. Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals
  23. Steroid binding properties of the 2nd WHO International Standard for sex hormone-binding globulin
  24. Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays
  25. Cancer Diagnostics
  26. Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
  27. Glycosylation of proteins in healthy and neoplastic human salivary glands – a preliminary study
  28. Infectious Diseases
  29. Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis
  30. Cardiovascular Diseases
  31. Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients
  32. High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction
  33. An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults
  34. The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents
  35. False positive troponin result caused by a true macrotroponin
  36. Letters to the Editor
  37. Patient safety: patient identification wristband errors
  38. Prevalence of hemolytic specimens referred for arterial blood gas analysis
  39. “Triage” of lymphoid malignancies in the peripheral blood using the Extended Immunofluorescent Application of the CELL-DYN Sapphire automated hematology analyzer
  40. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.138/html?lang=de
Button zum nach oben scrollen